Renal Dysfunction Is the Most Important Independent Predictor of Mortality in Cirrhotic Patients With Spontaneous Bacterial Peritonitis

Clinical Gastroenterology and Hepatology

Volumn 9, Issue 3, 2011, Pages 260-265

  Tandon, Puneeta ^a,b   Garcia Tsao, Guadalupe ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

BUN; Hospital Acquired Infections; Liver Disease; Prognosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA FETOPROTEIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL; CIPROFLOXACIN; COTRIMOXAZOLE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; IMMUNOGLOBULIN; INTERLEUKIN 6; NORFLOXACIN; POTASSIUM; PROTEIN; SODIUM; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; UREA;

ABDOMINAL PAIN; ACUTE PHYSIOLOGY AND CHRONIC HEALTH EVALUATION SCORE; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALCOHOL CONSUMPTION; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; ASCITES FLUID; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTEREMIA; BACTERIAL PERITONITIS; BACTERIUM CULTURE; BILIRUBIN BLOOD LEVEL; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; CELL COUNT; CELL CULTURE; CHILD PUGH SCORE; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DIARRHEA; DIASTOLIC BLOOD PRESSURE; ESCHERICHIA COLI; FEVER; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GASTROINTESTINAL HEMORRHAGE; GENDER; HEART RATE; HEMOGLOBIN BLOOD LEVEL; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HEPATITIS C; HIGH RISK PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ILEUS; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INTENSIVE CARE; KIDNEY DISEASE; KIDNEY FUNCTION; LEUKOCYTE COUNT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; MEAN ARTERIAL PRESSURE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; MULTIPLE ORGAN FAILURE; MULTIVARIATE ANALYSIS; NUTRITIONAL STATUS; PATIENT CARE; POLYMORPHONUCLEAR CELL; POTASSIUM BLOOD LEVEL; PREDICTION; PRIVATE HOSPITAL; PROGNOSIS; PROTHROMBIN TIME; PUBLIC HOSPITAL; REINFECTION; SCORING SYSTEM; SENSITIVITY ANALYSIS; SHOCK; SODIUM BLOOD LEVEL; SODIUM URINE LEVEL; SURVIVAL; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE COUNT; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; VOMITING;

ACUTE KIDNEY INJURY; BACTERIAL INFECTIONS; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PERITONITIS; PROGNOSIS;

EID: 79951727162     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2010.11.038     Document Type: Article

References (27)

1. Tandon P., Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis 2008, 28:26-42.
2. Fernandez J., Navasa M., Gomez J., et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002, 35:140-148.
3. Navasa M., Follo A., Llovet J.M., et al. Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology 1996, 111:1011-1017.
4. Sort P., Navasa M., Arroyo V., et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999, 341:403-409.
5. Toledo C., Salmeron J.M., Rimola A., et al. Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime. Hepatology 1993, 17:251-257.
6. Follo A., Llovet J.M., Navasa M., et al. Renal impairment following spontaneous bacterial peritonitis in cirrhosis. Incidence, clinical course, predictive factors and prognosis. Hepatology 1994, 20:1495-1501.
7. Navasa M., Follo A., Filella X., et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology 1998, 27:1227-1232.
8. Llovet J.M., Moitinho E., Sala M., et al. Prevalence and prognostic value of hepatocellular carcinoma in cirrhotic patients presenting with spontaneous bacterial peritonitis. J Hepatol 2000, 33:423-429.
9. Terg R., Cobas S., Fassio E., et al. Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study. J Hepatol 2000, 33:564-569.
10. Thuluvath P.J., Morss S., Thompson R. Spontaneous bacterial peritonitis-in-hospital mortality, predictors of survival, and health care costs from 1988 to 1998. Am J Gastroenterol 2001, 96:1232-1236.
11. Cereto F., Molina I., Gonzalez A., et al. Role of immunosuppression in the development of quinolone-resistant Escherichia coli spontaneous bacterial peritonitis and in the mortality of E. coli spontaneous bacterial peritonitis. Aliment Pharmacol Ther 2003, 17:695-701.
12. Soylu A.R., Dokmeci G., Tezel A., et al. Predictors of short-term outcome of spontaneous bacterial peritonitis in Turkish cirrhotic patients. J Gastroenterol Hepatol 2005, 20:657-660.
13. Shaw E., Castellote J., Santin M., et al. Clinical features and outcome of spontaneous bacterial peritonitis in HIV-infected cirrhotic patients: a case-control study. Eur J Clin Microbiol Infect Dis 2006, 25:291-298.
14. Song J.Y., Jung S.J., Park C.W., et al. Prognostic significance of infection acquisition sites in spontaneous bacterial peritonitis: nosocomial versus community acquired. J Korean Med Sci 2006, 21:666-671.
15. Cho J.H., Park K.H., Kim S.H., et al. Bacteremia is a prognostic factor for poor outcome in spontaneous bacterial peritonitis. Scand J Infect Dis 2007, 39:697-702.
16. Terg R., Gadano A., Cartier M., et al. Serum creatinine and bilirubin predict renal failure and mortality in patients with spontaneous bacterial peritonitis: a retrospective study. Liver Int 2009, 29:415-419.
17. Nobre S.R., Cabral J.E., Gomes J.J., et al. In-hospital mortality in spontaneous bacterial peritonitis: a new predictive model. Eur J Gastroenterol Hepatol 2008, 20:1176-1181.
18. Cereto F., Herranz X., Moreno E., et al. Role of host and bacterial virulence factors in Escherichia coli spontaneous bacterial peritonitis. Eur J Gastroenterol Hepatol 2008, 20:924-929.
19. Bert F., Panhard X., Johnson J., et al. Genetic background of Escherichia coli isolates from patients with spontaneous bacterial peritonitis: relationship with host factors and prognosis. Clin Microbiol Infect 2008, 14:1034-1040.
20. Cheong H.S., Kang C.I., Lee J.A., et al. Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis. Clin Infect Dis 2009, 48:1230-1236.
21. Kim S.U., Kim Dy, Lee C.K., et al. Ascitic fluid infection in patients with hepatitis B virus-related liver cirrhosis: culture-negative neutrocytic ascites versus spontaneous bacterial peritonitis. J Gastroenterol Hepatol 2010, 25:122-128.
22. Navasa M., Forns X., Sanchez V., et al. Quality of life, major medical complications and hospital service utilization in patients with primary biliary cirrhosis after liver transplantation. J Hepatol 1996, 25:129-134.
23. Sigal S.H., Stanca C.M., Fernandez J., et al. Restricted use of albumin for spontaneous bacterial peritonitis. Gut 2007, 56:597-599.
24. Terra C., Guevara M., Torre A., et al. Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score. Gastroenterology 2005, 129:1944-1953.
25. Singh N., Wagener M.M., Gayowski T. Changing epidemiology and predictors of mortality in patients with spontaneous bacterial peritonitis at a liver transplant unit. Clin Microbiol Infect 2003, 9:531-537.
26. Acevedo J., Fernandez J., Castro M., et al. Current efficacy of recommended empirical antibiotic therapy in patients with cirrhosis and bacterial infection. J Hepatol 2009, 50(Suppl 1). S5 (abstract).
27. Garcia-Tsao G., Lim J.K. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol 2009, 104:1802-1829.